Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Loxo Oncology, Inc. | 4,188,920 | reported | 10 Jan 2017 | tx 1+160,000 |
| Zeltiq Aesthetics Inc | 3,597,742 | reported | 14 Nov 2013 | tx 1−575,000 |
| AGILE THERAPEUTICS INC | 2,983,797 | reported | 23 Jan 2015 | tx 1+811,966 |
| Versartis, Inc. | 2,139,568 | reported | 27 Jan 2015 | tx 12+2,139,568−22,247,535 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jan 2017 | PURCHASE | Loxo Oncology, Inc. | 160,000 | 31.00 USD | first after silence |
| 27 Jan 2015 | PURCHASE | Versartis, Inc. | 145,000 | 17.25 USD | |
| 23 Jan 2015 | PURCHASE | AGILE THERAPEUTICS INC | 811,966 | 5.85 USD | |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 128,695 | — | |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 56,939 | — | |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 477,115 | — | |
| 26 Mar 2014 | PURCHASE | Versartis, Inc. | 60,000 | 21.00 USD | |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 35,104 | — | |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 1,236,715 | — | |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 5,486,820 | 0.00 USD | deriv |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 654,796 | 0.00 USD | deriv |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 1,479,993 | 0.00 USD | deriv |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 403,704 | 0.00 USD | deriv |
| 26 Mar 2014 | CONVERSION | Versartis, Inc. | 14,222,222 | 0.00 USD | deriv |
| 14 Nov 2013 | SALE | Zeltiq Aesthetics Inc | 575,000 | 12.22 USD |
1 purchase reported after at least 12 months of silence — most recent on 10 Jan 2017.